Skip to main content
Clinical Trials/NCT04223284
NCT04223284
Completed
Not Applicable

Olfactory Odour Stimulation for Metabolism Control - the "OLFAMET-Study"

University Hospital, Basel, Switzerland1 site in 1 country41 target enrollmentDecember 10, 2019
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
University Hospital, Basel, Switzerland
Enrollment
41
Locations
1
Primary Endpoint
Change of area under blood glucose curve (AUBGC)
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

In this preliminary short-term study it is investigated, whether a short olfactory stimulation with D-Limonene leads to an acute improvement of glucose metabolism in patients with obesity.

Registry
clinicaltrials.gov
Start Date
December 10, 2019
End Date
October 13, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
University Hospital, Basel, Switzerland
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age 18-70 years
  • Obesity (BMI ≥35 kg/m2)
  • Written informed consent
  • Normosmia (defined by sniffin Sticks test)

Exclusion Criteria

  • Known allergy to D-Limonene, citrus fruits, citrus flavours, SLVO
  • Regular smoking
  • Current illicit drug abuse including daily marijuana and cannabidiol (CBD) consumption (alcohol ≤2 drinks per day allowed)
  • Diabetes mellitus
  • Pre-Treatment with insulin sensitizing drugs including GLP-1 analogues
  • History of neurodegenerative diseases, severe head trauma
  • Severe renal impairment (e.g. estimated glomerular filtration rate \<30 ml/min/m2)
  • Known liver cirrhosis or other severe liver impairment
  • Acute upper respiratory tract infection
  • Uncontrolled dysthyroidism

Outcomes

Primary Outcomes

Change of area under blood glucose curve (AUBGC)

Time Frame: Time Frame: baseline blood exam (timepoint 0) and further blood collections: 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution

area under the blood glucose curve (AUBGC) during a mixed-meal test after stimulation with D-Limonene compared to baseline

Secondary Outcomes

  • Change in plasma levels of glucagon-like peptide 1 (GLP-1)(Time Frame: baseline blood exam (timepoint 0) and further blood collections after 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Change in plasma levels of Leptin(Time Frame: baseline blood exam (timepoint 0) and further blood collections after 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Change in plasma Levels of Interleukin-6(Time Frame: baseline blood exam (timepoint 0) and further blood collections after 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Change in plasma peak glucose levels(Time Frame: baseline blood exam (timepoint 0) and further blood collections: 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Change in plasma levels of lipids like LDL-cholesterine, total cholesterine, triglycerides(Time Frame: baseline blood exam (timepoint 0) and further blood collections: 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Visual Analogue Scale (VAS score)(Time Frame: baseline VAS score (timepoint 0) and VAS scores will be evaluated after 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Change in plasma insulin levels(Time Frame: baseline blood exam (timepoint 0) and further blood collections: 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Change in heart rate(Blood pressure and heart rate will be measured at the following times: baseline (timepoint 0) and 30, 60, 120 minutes drinking a standardized mixed-meal solution)
  • Change in blood pressure(Blood pressure and heart rate will be measured at the following times: baseline (timepoint 0) and 30, 60, 120 minutes drinking a standardized mixed-meal solution)
  • Change in plasma levels of gastric inhibitory polypeptide (GIP)(Time Frame: baseline blood exam (timepoint 0) and further blood collections after 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Change in plasma levels of Peptide YY (PYY)(Time Frame: baseline blood exam (timepoint 0) and further blood collections after 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Change in plasma Levels of C-reactive protein(Time Frame: baseline blood exam (timepoint 0) and further blood collections after 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • AUBGC(Time Frame: baseline blood exam (timepoint 0) and further blood collections: 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Change in plasma levels of Ghrelin(Time Frame: baseline blood exam (timepoint 0) and further blood collections after 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)
  • Change in plasma levels of Glucagon(Time Frame: baseline blood exam (timepoint 0) and further blood collections after 5, 15, 30, 60, 90 and 120 minutes after drinking a standardized mixed-meal solution)

Study Sites (1)

Loading locations...

Similar Trials